Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plantae Bioscience
Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Plantae Bioscience uses proprietary gene editing and plant biotechnologies to enhance health-focused traits in food crops, reducing undesirable compounds such as saponins in peas and boosting bioactive compounds like phytosterols in tomatoes and lettuce. No clinical (human health) results, but strong early-stage proof-of-concept in plant targets.
- Therapeutic areas
- Metabolic DisordersOther
- Modalities
- CRISPR-based therapyGenome editing
- Industry
- Non-Drug Biotech
02
Partnerships
Weizmann Institute of ScienceYeda (Weizmann tech transfer company)
Beyond the preview
Go deeper on Plantae Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plantae Bioscience.